| (19) |
 |
|
(11) |
EP 1 440 709 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
08.12.2004 Bulletin 2004/50 |
| (43) |
Date of publication A2: |
|
28.07.2004 Bulletin 2004/31 |
| (22) |
Date of filing: 17.10.2000 |
|
|
| (84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
| (30) |
Priority: |
21.10.1999 GB 9924958
01.09.2000 GB 0021520
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
00309129.5 / 1129706 |
| (71) |
Applicants: |
|
- Pfizer Limited
Sandwich, Kent CT13 9NJ (GB)
GB
- PFIZER INC.
New York, N.Y. 10017 (US)
AT BE CH LI CY DE DK ES FI FR GR IE IT LU NL PT SE
|
|
| (72) |
Inventors: |
|
- Forster, Eliot Richard
Sandwich, Kent CT13 9NJ (GB)
- Koppiker, Nandan Parmanand
Sandwich, Kent CT13 9NJ (GB)
|
| (74) |
Representative: Stuart, Peter Graham |
|
Pfizer Limited, European Patents Department, Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB) |
|
| |
|
| (54) |
Combinations comprising cGMP PDE5 inhibitors. |
(57) The present invention describes a combination comprising a c-GMP PDE5 inhibitor with
gabapentin or pregabalin, particularly for the treatment of neuropathy.